Many employers hold off on coverage of Wegovy and similar drugs amid cost concerns and the prospect of cheaper options down the road
Read Full Story
Latest posts by Market Watch (see all)
- FA Center: Inflation will have to get a lot worse to justify gold’s current price - December 11, 2023
- : Small-business owners face a punishing cocktail of labor shortages, inflation and rising rates. But some are finding fresh ways to thrive. - December 11, 2023
- : Goldman hires Wells Fargo executive as head of transactional banking - December 11, 2023